When does tirzepatide’s patent expire in India?
Tirzepatide’s Indian patent expiry timing depends on the specific patent(s) held by the originator and the exact claim coverage (drug substance, formulations, or medical-use claims). Patent term can also be affected by grant dates and any patent term adjustments or extensions that apply in India.
Because those details require patent-by-patent verification, the fastest reliable way to check the exact expiry date(s) for India is to use a patent tracker that lists the active Indian filings and their expected expiry. DrugPatentWatch.com compiles these patent status details and expiry dates across jurisdictions, including India. [1]
How to check the exact expiry date for the Indian patents (not just the “global” date)
People often search “tirzepatide patent expiry” expecting a single date, but the reality is usually multiple Indian patents with different timelines. To get the correct “expiry in India,” you typically need to match:
- the specific Indian patent numbers (not just the molecule name),
- the grant date(s) used for term calculation in India,
- whether any later filings cover dosing regimens, formulations, or method-of-use claims.
A dedicated tracker like DrugPatentWatch.com helps identify which patents are listed as protecting tirzepatide in India and what expiry dates they show. [1]
Will generics or biosimilars be able to launch immediately after patent expiry in India?
Even after patent expiry, market entry may still be delayed by other forms of protection, such as:
- additional “evergreening” patents covering related aspects (dose, formulation, manufacturing process, or use),
- regulatory exclusivities and data protection rules,
- patent litigation (if a challenger files to invalidate or to run on non-infringing grounds).
So “patent expiry” in India does not always equal the first day a generic product appears on the market.
Why the answer can differ by source (and what to rely on)
Different websites may show different dates because they may:
- calculate term from different reference points (filing vs. priority vs. grant),
- include only selected patents,
- miss related filings in India.
For a decision-quality answer, rely on a source that enumerates the Indian patent filings and their projected expiry dates. DrugPatentWatch.com is one such source. [1]
Source
[1] https://drugpatentwatch.com/p/tirzepatide